Клиническая онкогематология. Фундаментальные исследования и клиническая практика
Clinical Oncohematology. Basic Research and Clinical Practice
ISSN 1997-6933 (print)
ISSN 2500-2139 (online)
Русский English
  • Register
  • Login
Skip to main content Skip to main navigation menu Skip to site footer
Clinical Oncohematology
Basic Research and Clinical Practice

ИФ РИНЦ:     0,587
H-INDEX:        16

  • Home
  • About the Journal
    • Aims and Scope
    • Editorial Masthead
    • Peer Review
    • Publishing Ethics and Malpractice Statement
    • Indexing and Abstracting
    • Ownership, management and funding
    • Open Access Policy and Publication Fee
  • Articles
    • Current
    • Journal pre-proofs
    • Archive
    • SUPPLEMENT
  • Sections
    • LYMPHOID TUMORS
    • MYELOID TUMORS
    • BONE MARROW TRANSPLANTATION
    • ANEMIAS
    • AUTOIMMUNE DISEASES
    • CLINICAL TRIALS
    • NOVEL CORONAVIRUS INFECTION
    • NEWS
    • NEW TECHNOLOGIES
    • REVIEWS
    • COMPLICATIONS OF CHEMOTHERAPY
    • PRACTICAL RECOMMENDATIONS
    • RARE HEMATOLOGICAL TUMORS AND SYNDROMES
    • EXPERIMENTAL STUDIES
  • Submission
  • Register
  • Login
  1. Home /
  2. Search

Search

Advanced filters
Published After
Published Before

Search Results

##search.searchResults.foundPlural##
  • Efficacy and Safety of Glofitamab Therapy in Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma: A United Russian Experience Based on the Compassionate Use Program

    Liudmila Valerevna Fedorova, N.B. Mikhailova, K.V. Lepik, A.M. Chekalov, O.G. Smykova, V.V. Markelov, G.S. Tumyan, A.A. Semenova, A.V. Arakelyan, L.S. Butaev, Iu.A. Oleinik, V.V. Ptushkin, Ya.K. Mangasarova, A.U. Magomedova, E.S. Gitelzon, N.G. Gabeeva, D.A. Koroleva, A.K. Smolianinova, E.E. Zvonkov, Iu.S. Osipov, N.V. Stepanova, T.V. Krinitsina, Yu.I. Podmankova, G.N. Khusainova, L.F. Mukharlyamova, O.R. Smirnova, I.V. Ishmatova, A.A. Zverkova, S.S. Elkhova, S.A. Volchenkov, I.S. Zyuzgin, D.D. Ivanova, E.A. Baryakh, E.N. Misyurina, P.A. Zeinalova, F.M. Abbasbeyli, O.L. Timofeeva, Yu.E. Ryabukhina, M.A. Ulyanova, V.V. Basmanova, T.N. Tsyganok, V.Yu. Kimaikina, S.V. Samarina, E.V. Zubkova, S.V. Ovanesyan, A.I. Iskhakova, A.Yu. Kuvshinov, A.A. Kuzyaeva, G.K. Isaeva, M.I. Andrievskikh, O.Yu. Arzhanukhina, T.V. Shelekhova, I.V. Morozova, P.V. Makarovskaya, O.S. Samoilova, I.V. Vasileva, A.Yu. Terekhova, N.A. Falaleeva, V.A. Shuvaev, S.V. Vlasova, V.A. Lapin, V.I. Bakhtina, A.D. Kulagin
    180-190
    01.04.2026
  • Primary Central Nervous System Lymphoma: A Literature Review, Diagnosis, Treatment, and Prognosis

    Selmi Faikovna Ramazanova, A.V. Arakelyan, A.A. Semenova, O.Yu. Baranova, D.N. Tupitsyna, M.Yu. Kichigina, O.P. Trofimova, G.D. Petrova, A.S. Subbotin, V.O. Shpirko, U.G. Koshkina, N.O. Zemlyakov, K.R. Gadzhibekov, G.S. Tumyan
    191-203
    01.04.2026
  • Clinical Features and Treatment Outcomes of HIV-Associated Diffuse Large B-Cell Lymphoma

    Anastasia Borisovna Galitsyna, N.A. Falaleeva, O.V. Levkovskiy, V.A. Shuvaev, A.Yu. Terekhova, M.G. Syadrin, E.A. Norot, A.M. Chelmakov, S.A. Ivanov, A.D. Kaprin
    49-58
    01.01.2026
  • Personalized Approach to Treatment of Newly Diagnosed Diffuse Large B-Cell Lymphoma Patients with Respect to Molecular Landscape: A Case Report and Literature Review

    Marat Albertovich Mingalimov, E.A. Baryakh, T.N. Tolstykh, A.V. Misyurin, L.A. Kesaeva, A.S. Mkrtchyan, A.M. Kovrigina, E.N. Misyurina, M.S. Orlova, T.S. Chudnova, D.D. Ivanova, O.L. Kochneva, S.S. Andreev, K.V. Yatskov, I.V. Samsonova, M.A. Lysenko
    177-183
    01.04.2025
  • Diffuse Large B-Cell Lymphoma with High Risk of Central Nervous System Damage: A Literature Review, Prevention, Treatment, and Prognosis

    Selmi Faikovna Ramazanova, A.V. Arakelyan, A.A. Semenova, O.Yu. Baranova, D.N. Tupitsyna, M.Yu. Kichigina, I.Z. Zavodnova, E.V. Paramonova, A.S. Antipova, V.O. Shpirko, Yu.I. Klyuchagina, U.G. Koshkina, G.S. Tumyan
    51-64
    01.01.2025
  • The Prognostic Value of Cytotoxic CD8-Positive Т-Lymphocytes of the Reactive Tumor Microenvironment in Diffuse Large B-Cell Lymphoma

    Elena Viktorovna Vaneeva, V.A. Rosin, D.A. Dyakonov, N.V. Glubokovskikh
    266-272
    01.07.2024
  • Treatment of Diffuse Large B-Cell Lymphoma at the Moscow City Clinical Hospital No. 52: A Retrospective Clinical Trial Based on the Single-Center Experience and Analysis of Data from Its In-House Registry

    Marat Albertovich Mingalimov, E.A. Baryakh, Yu.Yu. Polyakov, E.N. Misyurina, E.I. Zhelnova, K.V. Yatskov, A.B. Makeshova, T.N. Tolstykh, TS Chudnova, D.D. Ivanova, O.L. Kochneva, I.V. Samsonova, M.A. Lysenko
    11-17
    17.05.2024
  • The Value of Combined PET/CT in Diffuse Large B-Cell Lymphoma: Historical Background, Evolution of Views, and Current Opportunities of the Method (Literature Review)

    Artem Andreevich Vovchenko, N.A. Falaleeva, A.A. Danilenko, A.Yu. Terekhova, M.M. Khodzhibekova, A.M. Chelmakov, A.G. Zamotina, A.S. Dikova, S.V. Ruchkova, Yu.V. Sinitsyna, V.Yu. Kovalskaya, A.N. Perepelitsyna, A.N. Balashova, D.A. Manaenkov, S.A. Ivanov
    66-75
    17.05.2024
  • Therapy Optimization in Newly Diagnosed Diffuse Large B-Cell Lymphoma: Efficacy and Safety of the R-SD-EPOCH ± HDMTX Program Under Single-Center Non-Randomized Prospective Clinical Trial (Preliminary Results)

    Marat Albertovich Mingalimov
    173-179
    01.04.2024
  • Plasma Cell-Free DNA in Patients with Diffuse Large B-Cell and B-Cell High-Grade (Double Hit/Triple Hit) Lymphomas

    Svetlana Yurevna Smirnova, E.E. Nikulina, N.G. Gabeeva, D.A. Koroleva, S.A. Tatarnikova, A.K. Smol’yaninova, E.G. Gemdzhian, E.E. Zvonkov, A.B. Sudarikov
    200-208
    03.03.2023
  • Significance of the Expression of pAKT1 and pSyk Activation Proteins in Diffuse Large B-Cell Lymphoma

    Elena Viktorovna Vaneeva, V.A. Rosin, D.A. Dyakonov, S.V. Samarina, I.V. Paramonov
    140-147
    01.04.2022
  • Treatment of Patients with Newly Diagnosed Diffuse Large B-Cell Lymphoma: A Systematic Review and Meta-Analysis

    Aleksander Sergeevich Luchinin
    130-139
    01.04.2022
  • Value of PD-L1 Protein Expression in the Combined Prognostic Model of Diffuse Large B-Cell Lymphoma

    Svetlana Valerevna Samarina, N.Yu. Semenova, N.V. Minaeva, D.A. Dyakonov, V.A. Rosin, E.V. Vaneeva, S.V. Gritsaev
    308-314
    01.07.2021
  • Pharmacoeconomic Analysis of R-DA-EPOCH and R-mNHL-BFM-90 Combination Immunochemotherapy in Patients with Prognostically Unfavorable Diffuse Large B-Cell Lymphoma within Randomized Multi-Center Clinical Trial DLBCL-2015

    Madina Olegovna Bagova, A.U. Magomedova, S.K. Kravchenko, R.I. Yagudina, V.G. Serpik, S.M. Kulikov, Yu.A. Chabaeva
    321-332
    01.07.2021
  • Immunohistochemical Subtype and Parameters of International Prognostic Index in the New Prognostic Model of Diffuse Large B-Cell Lymphoma

    S.V. Samarina, A.S. Luchinin, N.V. Minaeva, I.V. Paramonov, D.A. D’yakonov, E.V. Vaneeva, V.A. Rosin, S.V. Gritsaev
    385-390
    01.10.2019
  • Primary Bone Lymphomas: Long-Term Results of a Prospective Single-Center Trial

    Anna Konstantinovna Smol’yaninova, N.G. Gabeeva, V.E. Mamonov, S.A. Tatarnikova, L.G. Gorenkova, D.S. Badmadzhapova, A.M. Kovrigina, E.G. Gemdzhian, E.E. Zvonkov
    247-262
    01.07.2019
  • Analysis Results of the Regional Registry of Patients with Diffuse Large B-cell Lymphoma: Risk Factors and Chemo-Immunotherapy Issues

    Kamil’ Daniyalovich Kaplanov, N.P. Volkov, T.Yu. Klitochenko, I.V. Matveeva, A.L. Shipaeva, M.N. Shirokova, N.V. Davydova, E.G. Gemdzhian, D.S. Abramov, D.M. Konovalov, G.L. Snigur, N.A. Red’kina
    154-164
    01.04.2019
  • Clinical and Hematological Predictors of Response to First-Line Therapy in Patients with Diffuse Large B-Cell Lymphoma

    Svetlana Valer’evna Samarina, E.L. Nazarova, N.V. Minaeva, E.N. Zotina, I.V. Paramonov, S.V. Gritsaev
    68-72
    01.01.2019
  • Clinical and Prognostic Value of Molecular Markers of Diffuse Large B-Cell Lymphoma

    S.M. Rastorguev, D.A. Koroleva, E.S. Boulygina, S.V. Tsygankova, N.G. Goncharov, O.S. Naraikin, N.G. Gabeeva, E.E. Zvonkov, A.V. Nedoluzhko
    95-100
    01.01.2019
  • Prognostic and Differential Diagnostic Value of Standardized Uptake Volume (SUV) of Fluorodeoxyglucose in Patients with Hodgkin’s Lymphoma

    Anatolii Anatol’evich Rukavitsyn, S.I. Kurbanov, O.A. Rukavitsyn
    182-186
    01.04.2017
  • MYC and BCL2 Protein Expression in Patients with Diffuse Large B-cell Lymphoma

    Anna Evgen’evna Misyurina, A.M. Kovrigina, E.A. Baryakh, V.A. Misyurin, S.K. Kravchenko, S.M. Kulikov, E.G. Gemdzhyan, T.N. Obukhova, A.N. Kopylov, A.U. Magomedova, A.I. Vorob’ev
    44–53
    01.01.2015
  • Role of c-MYC, BCL2, and BCL6 Expression in Pathogenesis of Diffuse Large B-Cell Lymphoma

    A.E. Misyurina, V.A. Misyurin, E.A. Baryakh, A.M. Kovrigina, S.K. Kravchenko
    512-521
    01.10.2014
1 - 22 of 22 items

oa-antiplagiat

Антиплагиат

Make a Submission

Make a Submission

Banner ROHS

Russian Oncohematology Society

Indexing Databases

  • ISSN
  • cyberleninka cyberleninka
  • DOAJ
  • Web of Science
  • Scopus
  • Elsevier
  • CAS Source Index (CASSI)
  • NLM Catalog
  • British Library
  • РИНЦ
  • Science Index
  • SCImago
  • The European Library
  • Scholia
  • Journal Observatory
  • Scholar Google
  • IPR Smart
  • RSL
  • Ulrich's Serials Analysis System
  • ВИНИТИ
  • WorldCat
  • Research4Life
  • Lens
  • Mendeley
  • MIAR
  • OpenCitations
  • xueshu
  • OpenAlex
  • Scilit
  • Wikidata
  • na.neicon
  • Internet Archive scholar
  • ZDB catalogue
  • Keepers ISSN
  • RusMed
  • RCSI

Editor-in-Chief

Gayane Sepugovna Tumyan

ARCHIVE

2026
  • Issue 1 (2026)
2025
  • Issue 1 (2025)
  • Issue 2 (2025)
  • Issue 3 (2025)
  • Issue 4 (2025)
2024
  • Issue 1 (2024)
  • Issue 2 (2024)
  • Issue 3 (2024)
  • Issue 4 (2024)
2023
  • Issue 1 (2023)
  • Issue 2 (2023)
  • Issue 3 (2023)
  • Issue 4 (2023)
2022
  • Issue 1 (2022)
  • Issue 2 (2022)
  • Issue 3 (2022)
  • Issue 4 (2022)
2021
  • Issue 1 (2021)
  • Issue 2 (2021)
  • Issue 3 (2021)
  • Issue 4 (2021)
2020
  • Issue 1 (2020)
  • Issue 2 (2020)
  • Issue 3 (2020)
  • Issue 4 (2020)
2019
  • Issue 1 (2019)
  • Issue 2 (2019)
  • Issue 3 (2019)
  • Issue 4 (2019)
2018
  • Issue 1 (2018)
  • Issue 2 (2018)
  • Issue 3 (2018)
  • Issue 4 (2018)
2017
  • Issue 1 (2017)
  • Issue 2 (2017)
  • Issue 3 (2017)
  • Issue 4 (2017)
2016
  • Issue 1 (2016)
  • Issue 2 (2016)
  • Issue 3 (2016)
  • Issue 4 (2016)
2015
  • Issue 1 (2015)
  • Issue 2 (2015)
  • Issue 3 (2015)
  • Issue 4 (2015)
2014
  • Issue 1 (2014)
  • Issue 2 (2014)
  • Issue 3 (2014)
  • Issue 4 (2014)
2013
  • Issue 1 (2013)
  • Issue 2 (2013)
  • Issue 3 (2013)
  • Issue 4 (2013)
ALL ARCHIVE

Keywords

Most Read Articles
  • National Clinical Guidelines on Diagnosis and Treatment of Ph-Negative Myeloproliferative Neoplasms (Polycythemia Vera, Essential Thrombocythemia, and Primary Myelofibrosis) (Edition 2024)
    3450
  • National Clinical Guidelines on Diagnosis and Treatment of Ph-Negative Myeloproliferative Neoplasms (Polycythemia Vera, Essential Thrombocythemia, and Primary Myelofibrosis) (Edition 2020)
    1229
  • Phase 3 Clinical Trial of 300 mg Vamotinib Directly Compared with High-Dose Imatinib in Chronic Myeloid Leukemia Patients in Chronic Phase with Failure of Standard-Dose Imatinib: Interim Analysis
    903
  • Multiple myeloma (pathogenesis, clinical features, diagnosis, differential diagnosis). Part I
    846
  • Anemia of Chronic Diseases
    841

Partners

Roche
Novartis Pharma
AstraZeneca
AbbVie
Swedish Orphan Biovitrum / SOBI
Roche
Novartis Pharma
AstraZeneca
AbbVie
Swedish Orphan Biovitrum / SOBI

«PRACTICAL MEDICINE» LLC
115201, Moscow, 1st Kotlyakovsky Pereulok 3
Phone. +7 (495) 324-93-29
E-mail: org@bloodjournal.ru
medprint.ru


Copyright © Clinical Oncohematology. Basic Research and Clinical Practice 2026

Up